Literature DB >> 16207714

Endocytosis resumes during late mitosis and is required for cytokinesis.

Jill Kuglin Schweitzer1, Erin E Burke, Holly V Goodson, Crislyn D'Souza-Schorey.   

Abstract

Recent work has underscored the importance of membrane trafficking events during cytokinesis. For example, targeted membrane secretion occurs at the cleavage furrow in animal cells, and proteins that regulate endocytosis also influence the process of cytokinesis. Nonetheless, the prevailing dogma is that endosomal membrane trafficking ceases during mitosis and resumes after cell division is complete. In this study, we have characterized endocytic membrane trafficking events that occur during mammalian cell cytokinesis. We have found that, although endocytosis ceases during the early stages of mitosis, it resumes during late mitosis in a temporally and spatially regulated pattern as cells progress from anaphase to cytokinesis. Using fixed and live cell imaging, we have found that, during cleavage furrow ingression, vesicles are internalized from the polar region and subsequently trafficked to the midbody area during later stages of cytokinesis. In addition, we have demonstrated that cytokinesis is inhibited when clathrin-mediated endocytosis is blocked using a series of dominant negative mutants. In contrast to previous thought, we conclude that endocytosis resumes during the later stages of mitosis, before cytokinesis is completed. Furthermore, based on our findings, we propose that the proper regulation of endosomal membrane traffic is necessary for the successful completion of cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207714     DOI: 10.1074/jbc.M504497200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population.

Authors:  Jong Ah Kim; Christoffer Åberg; Anna Salvati; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

Review 2.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Vesicle trafficking plays a novel role in erythroblast enucleation.

Authors:  Ganesan Keerthivasan; Sara Small; Hui Liu; Amittha Wickrema; John D Crispino
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

Review 4.  The endocytic matrix.

Authors:  Giorgio Scita; Pier Paolo Di Fiore
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

5.  Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.

Authors:  Robert E Dejournett; Ryuji Kobayashi; Shujuan Pan; Chuanfen Wu; Laurence D Etkin; Richard B Clark; Oliver Bögler; Jian Kuang
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

6.  Negative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis.

Authors:  David Chetrit; Lior Barzilay; Galit Horn; Tom Bielik; Nechama I Smorodinsky; Marcelo Ehrlich
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

7.  Endosomal recycling controls plasma membrane area during mitosis.

Authors:  Emmanuel Boucrot; Tomas Kirchhausen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

Review 8.  Protein adaptation: mitotic functions for membrane trafficking proteins.

Authors:  Stephen J Royle
Journal:  Nat Rev Mol Cell Biol       Date:  2013-08-14       Impact factor: 94.444

9.  Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.

Authors:  Ilaria Cascone; Rasim Selimoglu; Cafer Ozdemir; Elaine Del Nery; Charles Yeaman; Michael White; Jacques Camonis
Journal:  EMBO J       Date:  2008-08-28       Impact factor: 11.598

10.  Rab5-mediated endocytosis of activin is not required for gene activation or long-range signalling in Xenopus.

Authors:  Anja I Hagemann; Xin Xu; Oliver Nentwich; Marko Hyvonen; James C Smith
Journal:  Development       Date:  2009-07-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.